New Delhi, July 31 -- The Indian pharmaceutical industry has hit back strongly at the recent tariff announcement by U.S. President Donald Trump, calling it a move that could hurt the American healthcare system more than India's economy.
Reacting to the U.S. decision to impose a 25 per cent tariff on Indian goods, Dilip Kumar, Chairman of Medical Tourism at the Chamber of Commerce, told ANI that the move aimed at damaging the Indian economy. However, he expressed confidence that it would not succeed.
"He is trying to kill the market of the Indian economy, but it is not going to happen," Kumar said.
"We are exporters, especially of medical equipment, pharmaceuticals, and disposables, which mostly come from India. The American market is d...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.